Abstract: The invention provides substituted quinoxalines having the general formulas where R1, R2, R3, and R4 are, inter alia, alkyl, aryl, or heteroaryl groups; Z is NH or O; and X is, inter alia, COOH or CONH2. The compounds of the invention have antiviral and immunomodulatory activity and are useful for treating infectious diseases, particularly viral infections.
Type:
Grant
Filed:
April 15, 2004
Date of Patent:
March 13, 2007
Assignee:
Valeant Research and Development
Inventors:
Haoyun An, Frank Rong, Jim Wu, Clayton Harris, Suetying Chow